Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: Results of a multicentre prospective study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 3, 2009, Pages 347-353

  Scott, Andrew M ^a   Gunawardana, Dishan H ^a   Wong, Joseph ^b   Kirkwood, Ian ^c   Hicks, Rodney J ^d   Ho Shon, Ivan ^e   Ramshaw, Jayne E ^f   Robins, Peter ^g  

^a AUSTIN HOSPITAL   (Australia)

^b WESLEY HOSPITAL   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f Australian and New Zealand Association of Physicians in Nuclear Medicine   (Australia)

^g SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Gallium; Low grade lymphoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; SCINTIGRAPHY;

DISEASE-FREE SURVIVAL; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60549102672     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0958-z     Document Type: Article

References (20)

1. MP MacManus RT Hoppe 1996 Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University J Clin Oncol 14 1282 1290
2. SB Paryani RT Hoppe RS Cox TV Colby SA Rosenberg HS Kaplan 1983 Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II Cancer 52 2300 2307
3. B Vaughan Hudson G Vaughan Hudson KA MacLennan L Anderson DC Linch 1994 Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy Br J Cancer 69 1088 1093
4. MK Gospodarowicz RS Bush TC Brown T Chua 1984 Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience Int J Radiat Oncol Biol Phys 10 489 497
5. P McLaughlin LM Fuller WS Velasquez JJ Butler FB Hagemeister JA Sullivan-Halley 1987 Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen J Clin Oncol 5 867 874
6. AD Murtha BA Rupnow J Hansosn SJ Knox R Hoppe 2001 Long-term follow-up of patients with stage III follicular lymphoma treated with primary radiotherapy at Stanford University Int J Radiat Oncol Biol Phys 49 3 15
7. JP Jacobs KJ Murray CJ Schultz JF Wilson MS Goswitz CW Stevens 1993 Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results J Clin Oncol 11 233 238
8. H Schöder J Meta C Yap M Ariannejad J Rao ME Phelps 2001 Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma J Nucl Med 42 1139 1143
9. S Partridge A Timothy MJ O'Doherty SF Hain S Rankin G Mikhaeel 2000 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution Ann Oncol 11 1273 1279
10. M Karam L Novak J Cyriac A Ali T Nazeer F Nugent 2006 Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas Cancer 107 175 183
11. 18F- FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL) Ann Oncol 12 825 830
12. DL Longo RL Schilsky L Blei R Cano GS Johnston RC Young 1980 Gallium-67 scanning: limited usefulness in staging patients with non-Hodgkin's lymphoma Am J Med 68 695 700
13. S Ben-Haim R Bar-Shalom O Israel N Haim R Epelbaum M Ben-Shachar 1996 Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma J Clin Oncol 14 1936 1942
14. 67Ga SPECT in evaluation of lymphoma: comparative Study Radiology 227 353 360
15. A Wirth JF Seymour RJ Hicks R Ware M Prince MP MacManus 2002 Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma Am J Med 112 262 268
16. 18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma Oncology 64 336 340
17. RH Blum JF Seymour A Wirth M MacManus RJ Hicks 2003 Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma Clin Lymphoma 4 43 49
18. N Tsukamoto M Kojima M Hasegawa N Oriuchi T Matsushima A Yokohama 2007 The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification Cancer 110 652 659
19. M Hoffmann K Kletter M Diemling A Becherer F Pfeffel V Petkov 1999 Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type Ann Oncol 10 1185 1189
20. H Schöder A Noy M Gönen L Weng D Green YE Erdi 2005 Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma J Clin Oncol 23 4643 4651